U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258550) titled 'Otago Exercise Programme and Physical Function in Older Adults in Sarawak' on Nov. 17. Brie... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259694) titled 'RCT on Traditional Exercise Interventions for Physical and Mental Health in Hearing-Impaired... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259954) titled 'Prediabetes and Metabolic Parameters Among Young Adults at Assiut University Hospital' on Se... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257861) titled 'Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life'... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259473) titled 'Factors Influencing Immunotherapy Response in dMMR/MSI-H Gastric/Gastroesophageal Junction A... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257003) titled 'A Nationwide Multicenter, Single-arm, Retrospective Study of Delayed Endoscopic DTI-BR After... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259369) titled 'The Effects of an App-based Acupressure on Alleviating Fatigue, Pruritus, and Sleep Quality ... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259213) titled 'A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC' on Nov. 15. Brief Summary:... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07257874) titled 'Intraoperative Pectoral Block vs IV Analgesia for Pain After Modified Radical Mastectomy' on... Read More
U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07258108) titled 'Lucentis Plus Tagolimumab in PD-L1+, HR+/HER2- Advanced Breast Cancer After CDK4/6 Inhibitor... Read More